Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects
NCT00654394 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2009-03-16
Summary
The purpose of this study is to examine the changes in the carotid artery when subjects receive high or low doses of rosuvastatin.
Conditions
- Carotid Artery Stenosis
- Hypercholesterolemia
Interventions
- DRUG
-
Rosuvastatin
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Tom Hatsukami · University of Washington, USA
-
Russell Esterline · AstraZeneca
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Completion
- 2004-08-31
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques
NCT02532309 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
NCT00240318 ·Status: COMPLETED ·Phase: PHASE3
-
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
NCT00654602 ·Status: COMPLETED ·Phase: PHASE3
-
A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques
NCT02305862 ·Status: UNKNOWN ·Phase: NA
-
Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis
NCT02594800 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate How AZD4144 Affects the Pharmacokinetics of Rosuvastatin in Healthy Participants
NCT06925854 ·Status: COMPLETED ·Phase: PHASE1
-
Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines
NCT00240292 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood
NCT04257032 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
NCT00574782 ·Status: COMPLETED
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
NCT05850091 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients
NCT00658463 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
NCT00965315 ·Status: AVAILABLE
-
The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease
NCT02516826 ·Status: UNKNOWN ·Phase: PHASE2
-
OLE Study to Evaluate Safety / Efficacy of ZD4522
NCT00654303 ·Status: COMPLETED ·Phase: PHASE3
-
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
NCT00329160 ·Status: COMPLETED ·Phase: PHASE4
-
Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
NCT02117453 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke
NCT03993236 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Healthy Men to Test the Influence of BI 1358894 on the Amount of the Medicines Rosuvastatin and Dabigatran in the Blood
NCT04099732 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
NCT06834932 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients
NCT07254221 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet
NCT02963116 ·Status: COMPLETED ·Phase: PHASE1
-
Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
NCT00240266 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
NCT00400439 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome
NCT04056169 ·Status: COMPLETED ·Phase: PHASE4
-
To Explore the Treatment Effect of Various Commercially Available Statins on Patients With Hyperlipidemia
NCT00726362 ·Status: COMPLETED